Johann Christoph Geller1,2, Armin Wöhrle3, Mathias Busch4, Albrecht Elsässer5, Thomas Kleemann6, Frank Birkenhauer7, Peter Bramlage8, Christian Veltmann9. 1. Klinik für Kardiologie, Abteilung für Rhythmologie und invasive Elektrophysiologie, Zentralklinik Bad Berka, Robert Koch Allee 9, 99437, Bad Berka, Germany. christoph.geller@zentralklinik.de. 2. Otto-von-Guericke University School of Medicine, Magdeburg, Germany. christoph.geller@zentralklinik.de. 3. Klinik für Kardiologie, Angiologie und Pneumologie, Klinikum Esslingen, Esslingen, Germany. 4. Klinik und Poliklinik für Innere Medizin B, Zentrum für Innere Medizin, Universitätsmedizin Greifswald, Greifswald, Germany. 5. Klinik für Kardiologie, Klinikum Oldenburg, Medizinischer Campus Universität Oldenburg, Oldenburg, Germany. 6. Medizinische Klinik B, Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany. 7. Abbott Medical GmbH, Eschborn, Germany. 8. Institut für Pharmakologie und Präventive Medizin, Mahlow, Germany. 9. Rhythmologie und Elektrophysiologie, Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Germany.
Abstract
PURPOSE: Inappropriate implantable cardioverter-defibrillator (ICD) shocks are associated with greater healthcare resource utilization, poorer quality-of-life, and higher mortality. We aimed to investigate the performance of enhanced supraventricular tachycardia (SVT) discrimination algorithms (morphology discrimination, rate stability, and sudden or chamber onset) for reducing inappropriate ICD therapies in patients with ICD/cardiac resynchronization therapy devices. METHODS: This prospective, non-randomized, multicenter study (ReduceIT) study took place at 56 sites across Germany and Estonia. Adults at risk of sudden cardiac death undergoing St. Jude Medical™ ICD or CRT-D implantation were included. The primary endpoint was freedom from inappropriate ICD shock at 12 months and was analyzed in the intention to treat (ITT) and per-protocol population. RESULTS: Overall, 733 patients (65.9 ± 11.4 years) were included, of which 40.9% and 59.1% received a single- and dual-chamber detection device, respectively. During follow-up (median 11.9 [0-21.6] months), 96.3% of patients experienced no inappropriate therapy (ITT). The sensitivity, specificity, and accuracy for VT/VF were 91.9%, 95.5%, and 94.7%, respectively. In the per-protocol population (n = 620), the proportion of patients free from inappropriate shock at 12 months was 98.4% (n = 610; 95% CI 97.1-99.2%) and exceeded the expected value of 93% (p < 0.0001) which was derived from the rates in the SPICE, ATPonFastVT, and DECREASE studies. A total of 44 patients (6.0%) died during follow-up, 19 deaths were cardiac-related which is consistent with a meta-analysis of EMPIRIC, MADIT-RIT, ADVANCE III, and PROVIDE. Serious device and procedure-related adverse effects occurred in 9.8% of patients. CONCLUSIONS: In ICD/CRT-D devices with advanced SVT discriminators, device programming according to clinical setting and detection chamber significantly reduces the rate of inappropriate ICD shocks without compromising patient safety. The algorithms and settings described herein have particular clinical importance and their employment may be of benefit to ICD recipients.
PURPOSE: Inappropriate implantable cardioverter-defibrillator (ICD) shocks are associated with greater healthcare resource utilization, poorer quality-of-life, and higher mortality. We aimed to investigate the performance of enhanced supraventricular tachycardia (SVT) discrimination algorithms (morphology discrimination, rate stability, and sudden or chamber onset) for reducing inappropriate ICD therapies in patients with ICD/cardiac resynchronization therapy devices. METHODS: This prospective, non-randomized, multicenter study (ReduceIT) study took place at 56 sites across Germany and Estonia. Adults at risk of sudden cardiac death undergoing St. Jude Medical™ ICD or CRT-D implantation were included. The primary endpoint was freedom from inappropriate ICD shock at 12 months and was analyzed in the intention to treat (ITT) and per-protocol population. RESULTS: Overall, 733 patients (65.9 ± 11.4 years) were included, of which 40.9% and 59.1% received a single- and dual-chamber detection device, respectively. During follow-up (median 11.9 [0-21.6] months), 96.3% of patients experienced no inappropriate therapy (ITT). The sensitivity, specificity, and accuracy for VT/VF were 91.9%, 95.5%, and 94.7%, respectively. In the per-protocol population (n = 620), the proportion of patients free from inappropriate shock at 12 months was 98.4% (n = 610; 95% CI 97.1-99.2%) and exceeded the expected value of 93% (p < 0.0001) which was derived from the rates in the SPICE, ATPonFastVT, and DECREASE studies. A total of 44 patients (6.0%) died during follow-up, 19 deaths were cardiac-related which is consistent with a meta-analysis of EMPIRIC, MADIT-RIT, ADVANCE III, and PROVIDE. Serious device and procedure-related adverse effects occurred in 9.8% of patients. CONCLUSIONS: In ICD/CRT-D devices with advanced SVT discriminators, device programming according to clinical setting and detection chamber significantly reduces the rate of inappropriate ICD shocks without compromising patient safety. The algorithms and settings described herein have particular clinical importance and their employment may be of benefit to ICD recipients.
Authors: Johannes B van Rees; C Jan Willem Borleffs; Mihály K de Bie; Theo Stijnen; Lieselot van Erven; Jeroen J Bax; Martin J Schalij Journal: J Am Coll Cardiol Date: 2011-02-01 Impact factor: 24.094
Authors: Leslie A Saxon; David L Hayes; F Roosevelt Gilliam; Paul A Heidenreich; John Day; Milan Seth; Timothy E Meyer; Paul W Jones; John P Boehmer Journal: Circulation Date: 2010-11-22 Impact factor: 29.690
Authors: Silvia G Priori; Carina Blomström-Lundqvist; Andrea Mazzanti; Nico Blom; Martin Borggrefe; John Camm; Perry Mark Elliott; Donna Fitzsimons; Robert Hatala; Gerhard Hindricks; Paulus Kirchhof; Keld Kjeldsen; Karl-Heinz Kuck; Antonio Hernandez-Madrid; Nikolaos Nikolaou; Tone M Norekvål; Christian Spaulding; Dirk J Van Veldhuisen Journal: Europace Date: 2015-08-29 Impact factor: 5.214
Authors: Silvia G Priori; Arthur A Wilde; Minoru Horie; Yongkeun Cho; Elijah R Behr; Charles Berul; Nico Blom; Josep Brugada; Chern-En Chiang; Heikki Huikuri; Prince Kannankeril; Andrew Krahn; Antoine Leenhardt; Arthur Moss; Peter J Schwartz; Wataru Shimizu; Gordon Tomaselli; Cynthia Tracy Journal: Heart Rhythm Date: 2013-07-31 Impact factor: 6.343
Authors: Jörg Otto Schwab; Hendrik Bonnemeier; Thomas Kleemann; Johannes Brachmann; Sven Fischer; Frank Birkenhauer; Frank Eberhardt Journal: Clin Res Cardiol Date: 2015-05-23 Impact factor: 5.460
Authors: Stefan M Schulz; Claudia Massa; Anna Grzbiela; Wilhelm Dengler; Georg Wiedemann; Paul Pauli Journal: Heart Lung Date: 2012-10-27 Impact factor: 2.210
Authors: Vincenzo Russo; Anna Rago; Vincenzo Ruggiero; Francesca Cavaliere; Valter Bianchi; Ernesto Ammendola; Andrea Antonio Papa; Vincenzo Tavoletta; Stefano De Vivo; Paolo Golino; Antonio D'Onofrio; Gerardo Nigro Journal: Front Cardiovasc Med Date: 2022-05-16